Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Mikami

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Crohn'S & Colitis 360|February 13, 2023
Efficacy of Calcineurin Inhibitors for Induction of Remission in Intestinal Behçet's DiseaseTakaaki Kawaguchi, Masayuki Fukata, Teppei Omori, et al.
Immunology Letters|October 2, 2012
MyD88-dependent interleukin-10 production from regulatory CD11b⁺Gr-1(high) cells suppresses development of acute cerulein pancreatitis in miceYuji Koike, Takanori Kanai, Keita Saeki, et al.
Immunology Letters|January 22, 2013
Dendritic cells administered intrarectally penetrate the intestinal barrier to break intestinal tolerance via Th2-medeiated colitis in miceTango Handa, Takanori Kanai, Toshiro Sato, et al.
Digestion|April 10, 2025
Factors Contributing to the Efficacy of Fecal Microbiota Transplantation for Diarrhea-Dominant Functional Bowel DisordersTsuyoshi Yamane, Tatsuhiro Masaoka, Chiharu Ishii, et al.
Plos One|April 30, 2013
IL-22-producing RORγt-dependent innate lymphoid cells play a novel protective role in murine acute hepatitisAtsuhiro Matsumoto, Takanori Kanai, Yohei Mikami, et al.
Inflammatory Bowel Diseases|August 29, 2014
Classical Th1 cells obtain colitogenicity by co-existence of RORγt-expressing T cells in experimental colitisKeiichiro Saigusa, Tadakazu Hisamatsu, Tango Handa, et al.
Crohn'S & Colitis 360|December 22, 2025
Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic StatusKatsuyoshi Matsuoka, Satoshi Motoya, Shinichiro Shinzaki, et al.
Biochemical and Biophysical Research Communications|October 2, 2012
Dysregulated balance of retinoid-related orphan receptor γt-dependent innate lymphoid cells is involved in the pathogenesis of chronic DSS-induced colitisKayoko Kimura, Takanori Kanai, Atsushi Hayashi, et al.
Journal of Crohn'S & Colitis|May 29, 2012
Long-term prognosis of patients with ulcerative colitis treated with cytapheresis therapyTetsuro Takayama, Takanaori Kanai, Katsuyoshi Matsuoka, et al.
Advances in Therapy|May 4, 2023
Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance StudyKatsuyoshi Matsuoka, Tadakazu Hisamatsu, Yohei Mikami, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Crohn'S & Colitis 360|February 13, 2023
Efficacy of Calcineurin Inhibitors for Induction of Remission in Intestinal Behçet's DiseaseTakaaki Kawaguchi, Masayuki Fukata, Teppei Omori, et al.
Immunology Letters|October 2, 2012
MyD88-dependent interleukin-10 production from regulatory CD11b⁺Gr-1(high) cells suppresses development of acute cerulein pancreatitis in miceYuji Koike, Takanori Kanai, Keita Saeki, et al.
Immunology Letters|January 22, 2013
Dendritic cells administered intrarectally penetrate the intestinal barrier to break intestinal tolerance via Th2-medeiated colitis in miceTango Handa, Takanori Kanai, Toshiro Sato, et al.
Digestion|April 10, 2025
Factors Contributing to the Efficacy of Fecal Microbiota Transplantation for Diarrhea-Dominant Functional Bowel DisordersTsuyoshi Yamane, Tatsuhiro Masaoka, Chiharu Ishii, et al.
Plos One|April 30, 2013
IL-22-producing RORγt-dependent innate lymphoid cells play a novel protective role in murine acute hepatitisAtsuhiro Matsumoto, Takanori Kanai, Yohei Mikami, et al.
Inflammatory Bowel Diseases|August 29, 2014
Classical Th1 cells obtain colitogenicity by co-existence of RORγt-expressing T cells in experimental colitisKeiichiro Saigusa, Tadakazu Hisamatsu, Tango Handa, et al.
Crohn'S & Colitis 360|December 22, 2025
Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic StatusKatsuyoshi Matsuoka, Satoshi Motoya, Shinichiro Shinzaki, et al.
Biochemical and Biophysical Research Communications|October 2, 2012
Dysregulated balance of retinoid-related orphan receptor γt-dependent innate lymphoid cells is involved in the pathogenesis of chronic DSS-induced colitisKayoko Kimura, Takanori Kanai, Atsushi Hayashi, et al.
Journal of Crohn'S & Colitis|May 29, 2012
Long-term prognosis of patients with ulcerative colitis treated with cytapheresis therapyTetsuro Takayama, Takanaori Kanai, Katsuyoshi Matsuoka, et al.
Advances in Therapy|May 4, 2023
Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance StudyKatsuyoshi Matsuoka, Tadakazu Hisamatsu, Yohei Mikami, et al.
Pageof 13